Irem brings over 15 years of investing and operating experience across healthcare tech-enabled services and healthcare technology. At Norwest, she focuses on venture and growth equity investments across healthcare, partnering with founders building scalable, tech-enabled platforms that improve outcomes and affordability.

Prior to Norwest, Irem was at Summit Partners, where she invested in growth-stage healthcare businesses and served as a board member or observer for companies spanning risk-bearing providers and tech-enabled services. Earlier, as a Principal at McKesson Ventures, she led investments in value-based care and pharma IT/services. Across her investing roles, she helped source or support companies including VaxCare (recapped by Blackstone), Landmark Health (acquired by Optum), IVX Health (recapped by Linden Capital Partners), OncoHealth, SHYFT Analytics (acquired by Medidata), Aetion (acquired by Datavant), AllyAlign Health (recapped by NEA to form Curana Health), Kyruus (acquired by RevSpring), and Evariant (acquired by Healthgrades).

Earlier in her career, Irem was part of the founding team at Burd Health, where she led the development and implementation of value-based initiatives for self-insured employers across network management, PBM contracts, and wellness programs. She also held product and business development roles at Omada Health and Caremerge (acquired by Icon), and was an intern at Andreessen Horowitz, where she sourced digital health investments.

Irem began her career as an investment associate at Madison Dearborn Partners and as an investment banking analyst in the Healthcare Group at Bank of America Merrill Lynch, advising on mergers and acquisitions across life sciences, medical devices, and healthcare services.

She holds a BS in Biomedical Engineering and Economics from Duke University and an MBA from the Stanford Graduate School of Business, where she was an Arbuckle Leadership Fellow and Co-President of the Healthcare Club.